Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Flynn

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Pharmacoepidemiology and Drug Safety|January 2, 2021
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysisDaniel R Morales, Tatiana Macfarlane, Thomas M MacDonald, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humansDaniel A Skelly, John P Graham, Mingshan Cheng, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Cell Reports|May 9, 2025
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 responseDaniel A Skelly, John P Graham, Mingshan Cheng, et al.
Neuro-Oncology|November 9, 2025
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Nature Communications|February 10, 2022
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy targetNourhan Abdelfattah, Parveen Kumar, Caiyi Wang, et al.
Cancer Discovery|June 15, 2019
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated FibroblastsEla Elyada, Mohan Bolisetty, Pasquale Laise, et al.
Nature Immunology|August 5, 2020
Mapping systemic lupus erythematosus heterogeneity at the single-cell levelDjamel Nehar-Belaid, Seunghee Hong, Radu Marches, et al.
Cell Metabolism|January 5, 2022
Targeting p21<sup>Cip1</sup> highly expressing cells in adipose tissue alleviates insulin resistance in obesityLichao Wang, Binsheng Wang, Nathan S Gasek, et al.
Cell Metabolism|November 23, 2021
Targeting p21<sup>Cip1</sup> highly expressing cells in adipose tissue alleviates insulin resistance in obesityLichao Wang, Binsheng Wang, Nathan S Gasek, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Pharmacoepidemiology and Drug Safety|January 2, 2021
Impact of EMA regulatory label changes on hydroxyzine initiation, discontinuation and switching to other medicines in Denmark, Scotland, England and the Netherlands: An interrupted time series regression analysisDaniel R Morales, Tatiana Macfarlane, Thomas M MacDonald, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humansDaniel A Skelly, John P Graham, Mingshan Cheng, et al.
Medrxiv : the Preprint Server for Health Sciences|June 17, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Cell Reports|May 9, 2025
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 responseDaniel A Skelly, John P Graham, Mingshan Cheng, et al.
Neuro-Oncology|November 9, 2025
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade gliomaKevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Nature Communications|February 10, 2022
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy targetNourhan Abdelfattah, Parveen Kumar, Caiyi Wang, et al.
Cancer Discovery|June 15, 2019
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated FibroblastsEla Elyada, Mohan Bolisetty, Pasquale Laise, et al.
Nature Immunology|August 5, 2020
Mapping systemic lupus erythematosus heterogeneity at the single-cell levelDjamel Nehar-Belaid, Seunghee Hong, Radu Marches, et al.
Cell Metabolism|January 5, 2022
Targeting p21<sup>Cip1</sup> highly expressing cells in adipose tissue alleviates insulin resistance in obesityLichao Wang, Binsheng Wang, Nathan S Gasek, et al.
Cell Metabolism|November 23, 2021
Targeting p21<sup>Cip1</sup> highly expressing cells in adipose tissue alleviates insulin resistance in obesityLichao Wang, Binsheng Wang, Nathan S Gasek, et al.
Pageof 16